Home
/
BioAge Labs, Inc.
/
Financials
/
Quarterly
BioAge Labs, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that BioAge Labs, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$2.05M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$2.41M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$1.45M
May 6, 2025
Q3
2025
Sep 30, 2024
$0
Nov 6, 2025
Q2
2025
Jun 30, 2024
$0
Aug 6, 2025
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($20.17M)
Nov 6, 2025
Q3
2025
Jun 30, 2025
($21.56M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($21.56M)
Aug 6, 2025
Q2
2025
Mar 31, 2025
($12.93M)
Aug 6, 2025
Q3
2025
Mar 31, 2025
($12.93M)
Nov 6, 2025
Q1
2025
Mar 31, 2025
($12.93M)
May 6, 2025
Q3
2025
Sep 30, 2024
($23.41M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($13.58M)
Aug 6, 2025
Q3
2025
Jun 30, 2024
($13.58M)
Nov 6, 2025
Q2
2025
Mar 31, 2024
($12.99M)
Aug 6, 2025
Q3
2025
Mar 31, 2024
($12.99M)
Nov 6, 2025
Q1
2025
Mar 31, 2024
($12.99M)
May 6, 2025
Q3
2024
Sep 30, 2023
($14.63M)
Nov 7, 2024
Q3
2024
Jun 30, 2023
($17.19M)
Nov 7, 2024
Q3
2024
Mar 31, 2023
($11.08M)
Nov 7, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($23.14M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($24.77M)
Aug 6, 2025
Q1
2025
Mar 31, 2025
($16.45M)
May 6, 2025
Q3
2025
Sep 30, 2024
($24.75M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($15.27M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($12.81M)
May 6, 2025
Q3
2024
Sep 30, 2023
($9.89M)
Nov 7, 2024